These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30693675)

  • 1. Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.
    Yaju Y; Tsubaki H
    Jpn J Nurs Sci; 2019 Oct; 16(4):433-449. PubMed ID: 30693675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study.
    Suzuki S; Hosono A
    Papillomavirus Res; 2018 Jun; 5():96-103. PubMed ID: 29481964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
    Skufca J; Ollgren J; Artama M; Ruokokoski E; Nohynek H; Palmu AA
    Vaccine; 2018 Sep; 36(39):5926-5933. PubMed ID: 30115524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events following HPV vaccination, Alberta 2006-2014.
    Liu XC; Bell CA; Simmonds KA; Svenson LW; Russell ML
    Vaccine; 2016 Apr; 34(15):1800-5. PubMed ID: 26921782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suspected Adverse Effects After Human Papillomavirus Vaccination: A Temporal Relationship Between Vaccine Administration and the Appearance of Symptoms in Japan.
    Ozawa K; Hineno A; Kinoshita T; Ishihara S; Ikeda SI
    Drug Saf; 2017 Dec; 40(12):1219-1229. PubMed ID: 28744844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining determinants for reporting suspected adverse events following HPV vaccination in Denmark.
    Ulendorf Jacobsen S; Valentiner-Branth P; Mølbak K
    Vaccine; 2018 Oct; 36(41):6158-6162. PubMed ID: 30201304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study.
    Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
    BMC Public Health; 2016 Aug; 15():708. PubMed ID: 27488178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the contextual nature of vaccine safety monitoring: Adverse events reporting after HPV-vaccination in Denmark, 2015.
    Schartau S; Heering Holt D; Lützen T; Rytter D; Mølbak K
    Vaccine; 2019 May; 37(19):2580-2585. PubMed ID: 30967312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase
    Chandler RE; Juhlin K; Fransson J; Caster O; Edwards IR; Norén GN
    Drug Saf; 2017 Jan; 40(1):81-90. PubMed ID: 27638661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compensation programs after withdrawal of the recommendation for HPV vaccine in Japan.
    Yuji K; Nakada H
    Hum Vaccin Immunother; 2016 May; 12(5):1321-4. PubMed ID: 26513303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
    Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
    Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance.
    Grimaldi-Bensouda L; Rossignol M; Koné-Paut I; Krivitzky A; Lebrun-Frenay C; Clet J; Brassat D; Papeix C; Nicolino M; Benhamou PY; Fain O; Costedoat-Chalumeau N; Courcoux MF; Viallard JF; Godeau B; Papo T; Vermersch P; Bourgault-Villada I; Breart G; Abenhaim L;
    J Autoimmun; 2017 May; 79():84-90. PubMed ID: 28190705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current knowledge of and attitudes toward human papillomavirus-related disease prevention among Japanese: A large-scale questionnaire study.
    Suzuki Y; Sukegawa A; Nishikawa A; Kubota K; Motoki Y; Asai-Sato M; Ueda Y; Sekine M; Enomoto T; Hirahara F; Yamanaka T; Miyagi E
    J Obstet Gynaecol Res; 2019 May; 45(5):994-1005. PubMed ID: 30723974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.
    Larson HJ; Wilson R; Hanley S; Parys A; Paterson P
    Hum Vaccin Immunother; 2014; 10(9):2543-50. PubMed ID: 25483472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus Vaccination Among Adults and Children in 5 US States.
    Du P; Camacho F; McCall-Hosenfeld J; Lengerich E; Meyers CM; Christensen ND
    J Public Health Manag Pract; 2015; 21(6):573-83. PubMed ID: 26035648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.
    van Klooster TM; Kemmeren JM; van der Maas NA; de Melker HE
    Vaccine; 2011 Jun; 29(28):4601-7. PubMed ID: 21549785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years.
    Einstein MH; Baron M; Levin MJ; Chatterjee A; Edwards RP; Zepp F; Carletti I; Dessy FJ; Trofa AF; Schuind A; Dubin G;
    Hum Vaccin; 2009 Oct; 5(10):705-19. PubMed ID: 19684472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions.
    Siegrist CA; Lewis EM; Eskola J; Evans SJ; Black SB
    Pediatr Infect Dis J; 2007 Nov; 26(11):979-84. PubMed ID: 17984802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.